We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-3.02%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$34.5B
AUM Growth
-$708M
(-2%)
Cap. Flow
+$1.23B
Cap. Flow
% of AUM
3.55%
Top 10 Holdings %
Top 10 Hldgs %
13.77%
Holding
2,852
New
233
Increased
919
Reduced
1,343
Closed
332
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enphase Energy
ENPH
|
+$342M |
| 2 |
Intel
INTC
|
+$276M |
| 3 |
TSMC
TSM
|
+$237M |
| 4 |
Procter & Gamble
PG
|
+$178M |
| 5 |
JPMorgan Chase
JPM
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$383M |
| 2 |
Occidental Petroleum
OXY
|
+$321M |
| 3 |
PayPal
PYPL
|
+$316M |
| 4 |
S&P Global
SPGI
|
+$145M |
| 5 |
Datadog
DDOG
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.57% |
| 2 | Healthcare | 17.95% |
| 3 | Financials | 9.89% |
| 4 | Industrials | 9.61% |
| 5 | Consumer Discretionary | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNR
1376
Core Natural Resources Inc
CNR
$3.92B
| $1.33M | ﹤0.01% |
20,700
-19,800
| -49% | -$1.25M |
|
|
CBAY
1377
DELISTED
Cymabay Therapeutics
CBAY
| $1.33M | ﹤0.01% |
379,838
+232,300
| +157% | +$834K |
|
1378
Forestar Group
FOR
$1.49B
| $1.33M | ﹤0.01% |
118,581
+34,000
| +40% | +$450K |
|
1379
Macerich
MAC
$7.46B
| $1.32M | ﹤0.01% |
166,800
-655,500
| -80% | -$6.37M |
|
|
ALLK
1380
DELISTED
Allakos
ALLK
| $1.32M | ﹤0.01% |
215,100
-698,600
| -76% | -$2.93M |
|
1381
Modine Manufacturing
MOD
$10B
| $1.31M | ﹤0.01% |
101,600
+57,800
| +132% | +$811K |
|
1382
Digital Turbine
APPS
$1.01B
| $1.31M | ﹤0.01% |
91,200
-100,574
| -52% | -$1.92M |
|
1383
AXT Inc
AXTI
$2.64B
| $1.31M | ﹤0.01% |
195,700
+500
| +0.3% | +$3.93K |
|
|
RADI
1384
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
| $1.31M | ﹤0.01% |
138,700
-15,200
| -10% | -$213K |
|
1385
RenaissanceRe
RNR
$13.9B
| $1.31M | ﹤0.01% |
9,300
-6,900
| -43% | -$957K |
|
1386
Columbus McKinnon
CMCO
$439M
| $1.3M | ﹤0.01% |
49,860
+7,000
| +16% | +$213K |
|
1387
National Healthcare
NHC
$3.58B
| $1.3M | ﹤0.01% |
20,591
+11,500
| +126% | +$799K |
|
1388
Merchants Bancorp
MBIN
$2.54B
| $1.3M | ﹤0.01% |
56,500
+4,000
| +8% | +$102K |
|
1389
Hershey
HSY
$37.8B
| $1.3M | ﹤0.01% |
5,900
-2,000
| -25% | -$448K |
|
1390
Oppenheimer Holdings
OPY
$1.17B
| $1.3M | ﹤0.01% |
41,986
-41,300
| -50% | -$1.45M |
|
|
SJR
1391
DELISTED
Shaw Communications Inc.
SJR
| $1.3M | ﹤0.01% |
53,400
-132,000
| -71% | -$3.5M |
|
1392
Highwoods Properties
HIW
$3.82B
| $1.3M | ﹤0.01% |
48,100
-3,100
| -6% | -$100K |
|
|
FBC
1393
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $1.29M | ﹤0.01% |
38,760
-45,100
| -54% | -$1.72M |
|
1394
Curtiss-Wright
CW
$25.9B
| $1.29M | ﹤0.01% |
9,300
-14,200
| -60% | -$2.02M |
|
1395
10x Genomics
TXG
$5.96B
| $1.29M | ﹤0.01% |
+45,400
| New | +$1.73M |
|
1396
Navigator Holdings
NVGS
$1.34B
| $1.29M | ﹤0.01% |
112,600
+48,300
| +75% | +$550K |
|
1397
The Honest Company
HNST
$413M
| $1.29M | ﹤0.01% |
368,000
-359,000
| -49% | -$1.32M |
|
1398
El Pollo Loco
LOCO
$505M
| $1.29M | ﹤0.01% |
144,300
-44,400
| -24% | -$418K |
|
1399
Travel + Leisure Co
TNL
$4.76B
| $1.28M | ﹤0.01% |
37,600
-14,600
| -28% | -$617K |
|
|
SP
1400
DELISTED
SP Plus Corporation
SP
| $1.28M | ﹤0.01% |
40,900
+20,200
| +98% | +$667K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2022 Portfolio in Review
As of Q3 2022, Two Sigma Advisers held 2,852 positions worth $34.5B, down 2% from $35.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Two Sigma Advisers deployed $1.23B of net new capital in Q3 2022, opening 233 new positions and adding to 919 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Netflix, an estimated $383M trimmed.
- Two Sigma Advisers's largest Q3 2022 buy was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
- Two Sigma Advisers added most to Enphase Energy in Q3 2022, an estimated $342M increase.
- Two Sigma Advisers's biggest Q3 2022 reduction was Netflix, cutting an estimated $383M.
- Two Sigma Advisers fully exited S&P Global in Q3 2022, selling an estimated $145M.
- Two Sigma Advisers's ten largest holdings make up 14% of its $34.5B portfolio in Q3 2022.
- Two Sigma Advisers opened 233 new positions and closed 332 in Q3 2022.
- Two Sigma Advisers's portfolio value fell 2% quarter-over-quarter to $34.5B.
Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.